Liver fibrosis, the hepatic stellate cell and tissue inhibitors of metalloproteinases

Histology and Histopathology

Volumn 15, Issue 4, 2000, Pages 1159-1168

  McCrudden, R ^a   Iredale, J P ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Collagenase; Hepatic Stellate Cell (HSC); Liver fibrosis; Matrix Metalloproteinase (MMP); Tissue Inhibitor of Metalloproteinase types 1 to 4 (TIMPs 1, 2, 3 and 4)

Indexed keywords

COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGENASE; CYTOKINE; MATRIX METALLOPROTEINASE; MATRIX PROTEIN; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; UNCLASSIFIED DRUG;

CELL ACTIVATION; DISEASE MODEL; EFFECTOR CELL; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MOLECULAR INTERACTION; MORTALITY; NONHUMAN; PHENOTYPE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; PROTEINASE INHIBITION; REVIEW; STELLATE CELL;

ANIMAL; HUMAN; LIVER; LIVER CIRRHOSIS; METALLOENDOPEPTIDASES; SUPPORT, NON-U.S. GOV'T; TISSUE INHIBITOR OF-METALLOPROTEINASE-3; TISSUE INHIBITOR-OF METALLOPROTEINASE-2; TISSUE-INHIBITOR OF METALLOPROTEINASE-1;

EID: 0033814218     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (Timp-3) and mapping of the timp3 gene to chromosome 22
2. Formation of extracellular matrix in normal rat liver: Lipocytes as a major source of proteoglycan
3. Degradation of matrix proteins in liver fibrosis
4. Matrix degradation in the liver
5. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen
6. Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes: Analysis of gene expression, protein synthesis and proteinase activity
7. The role of thrombocytes in liver fibrogenesis: Effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat storing cells
8. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells
9. Expression of tissue inhibitor of metalloproteinases-1 and -2 in increased in fibrotic human liver
10. Inhibition of processing of the primary transcript of the gene encoding tissue inhibitor of metalloproteinases (TIMP) by antisense TIMP RNA in mouse 3T3-cells
11. cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases
12. Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling
13. The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor
14. Insulin-like growth factor-II/mannose 6-phosphate receptor is expressed on CC14-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells
15. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2
16. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2)
17. Tissue inhibitor of metalloproteinases (TIMP, aka EPA) - Structure, control of expression and biological functions
18. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
19. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor
20. Involvement of AP1 and PEA3 binding sites in the regulation of murine tissue inhibitor of metalloproteinases-1 (TIMP-1) transcription
21. Human liver fibroblast capacity for synthesizing interstitial collagenase in vitro
22. Current approaches to the therapy of fibrotic diseases
23. Domain structure of human 72-kDa gelatinase type-IV collagenase characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions
24. Molecular mechanisms of hepatic fibrosis and principles of therapy
25. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet derived growth factor receptors
26. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver
27. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix
28. Interaction of 92-kDa Type-IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin
29. Human fibroblast collagenase
30. Distributions of retinoids, retinoid-binding proteins and related parameters in different types of liver cells isolated from young and old rats
31. Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver
32. TGF-beta and collagen-alpha (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload
33. Endothelin receptors in rat liver: Lipocytes as a contractile target for endothelin 1
34. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase
35. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2
36. Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1 (TIMP-1): Implications for regulation of matrix degradation in liver
37. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes
38. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis
39. Mechanisms of spontaneous resolution of rat liver fibrosis: Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors
40. The hepatic perisinusoidal stellate cell
41. Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2) - up-regulation by interleukin-6 and transforming growth factor-beta1
42. Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured lipocytes
43. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo
44. Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture
45. Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells
46. Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: Potential role in liver injury
47. Cultured human liver fat-storing cells produce monocyte chemotactic protein-1 - regulation by proinflammatory cytokines
48. Interferon-gamma-mediated activation of stat1 alpha regulates growth factor-induced mitogenesis
49. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells - cellular differentiation influences expression
50. The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CC14-induced cirrhosis
51. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis
52. Direct measurement of neutral collagenase activity in homogenates from baboon and human liver
53. Metalloproteinases and their inhibitors in matrix remodelling
54. The matrix-degrading metalloproteinases
55. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: Implication for a pathogenetic role in alcoholic liver fibrogenesis
56. Receptors for extracellular matrix components
57. The role of perisinusoidal cells in hepatic fibrogenesis. An electron microscopic study of acute carbon tetrachloride liver injury
58. In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in nonparenchymal liver cells
59. Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis
60. Cellular localization of type I, III and IV procollagen gene transcripts in normal and fibrotic human liver
61. Interstitial collagenase gene is differentially expressed in human liver and cultured fat-storing cells
62. The role of fat-storing cells in Disse space fibrogenesis in alcoholic liver disease
63. Serum collagenase activity in chronic liver diseases
64. Serum tissue inhibitor of metalloproteinases in patients with chronic liver disease and with hepatocellular carcinoma
65. The matrix metalloproteinases and their inhibitors
66. Proteinases in rheumatoid arthritis
67. Stromelysin is an activator of procollagenase
68. Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor
69. Role and regulation of metalloproteinases in connective tissue turnover
70. Metalloproteinases and tissue damage
71. The role of plasminogen activators in the regulation of connective tissue metalloproteinases
72. Clinical evaluation of serum tissue inhibitor of metalloproteinases-1 levels in patients with liver diseases
73. Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis
74. Collagenase activity in experimental hepatic fibrosis
75. Independent regulation of collagenase, 72kD progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta
76. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts
77. A new inhibitor of metalloproteinases from chicken - ChIMP- 3 - A 3rd member of the TIMP family
78. Collagenolytic activity in experimental cirrhosis of the liver
79. Enhanced hepatic collagen gene expression in a rodent model of hemochromatosis
80. Effects of platelet derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat storing cells
81. Secretion of insulin-like growth factor-1 and binding proteins by rat liver fat-storing cells: Regulatory role of platelet-derived growth factor
82. Regulation of macrophage colony-stimulating factor in liver fat-storing cells by peptide growth factors
83. Tenascin gene expression in rat liver and in rat liver cells
84. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture
85. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility
86. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures
87. Collagen types in normal and cirrhotic liver
88. A matrix metalloproteinase expressed on the surface of invasive tumour cells
89. Structural organization and chromosomal localization of the mouse collagenase type I gene
90. Stellate cells (vitamin A-storing cells) are the primary site of collagen synthesis in non-parenchymal cells in the liver
91. The arrangement of intra and intermolecular disulfide bonds in the carboxy terminal non collagenous aggregation and cross linking domain of basement membrane type IV collagen
92. Collagen production in fat-storing cells after carbon tetrachloride intoxication in the rat. Immunoelectron microscopic observation of type I, type III collagens, and prolyl hydroxylase
93. Granuloma collagenase and EDTA-sensitive neutral protease production in hepatic murine schistosomiasis
94. Liver collagenase in murine schistosomiasis
95. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library
96. Primary rat and mouse hepatic stellate cells express the macrophage inhibitor cytokine interleukin 10 during the course of activation in vitro
97. Interleukin-10 expression and function in experimental murine liver inflammation
98. Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein
99. Detection of alpha-2-macroglobulin, alpha-1-protease inhibitor, and neutral protease-antiprotease complexes within liver granulomas of schistosoma mansoni-infected mice
100. Transin (stromelysin) is expressed in early rat lipocyte primary culture
101. Transforming growth factor-beta enhances integrin expression and type-IV collagenase secretion in human monocytes
102. Perisinusoidal stellate cells (fat-storing cells, interstitial cells, lipocytes), their related structure in and around the liver sinusoids, and vitamin A-storing cells in extrahepatic organs
103. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72kDa progelatinase by fibroblast membranes
104. Structure of the human TIMP-3 gene and its cell cycle-regulated promoter
105. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment
106. Kupffer cell-derived 95kDa type IV collagenase/gelatinase B: Characterisation and expression in cultured cells
107. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture
108. Molecular cloning and expression analysis of the cDNA encoding rat tissue inhibitor of metalloproteinase-4